81 related articles for article (PubMed ID: 26563945)
41. The Atypical Receptor CCRL2 (C-C Chemokine Receptor-Like 2) Does Not Act As a Decoy Receptor in Endothelial Cells.
Mazzotti C; Gagliostro V; Bosisio D; Del Prete A; Tiberio L; Thelen M; Sozzani S
Front Immunol; 2017; 8():1233. PubMed ID: 29056935
[TBL] [Abstract][Full Text] [Related]
42. CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer.
Sozio F; Schioppa T; Laffranchi M; Salvi V; Tamassia N; Bianchetto-Aguilera FM; Tiberio L; Bonecchi R; Bosisio D; Parmentier M; Bottazzi B; Leone R; Russo E; Bernardini G; Garofalo S; Limatola C; Gismondi A; Sciumè G; Mantovani A; Del Prete A; Sozzani S
Cancer Immunol Res; 2023 Sep; 11(9):1280-1295. PubMed ID: 37343073
[TBL] [Abstract][Full Text] [Related]
43. Exploring CCRL2 chemerin binding using accelerated molecular dynamics.
Bufano M; Laffranchi M; Sozzani S; Raimondo D; Silvestri R; Coluccia A
Proteins; 2022 Sep; 90(9):1714-1720. PubMed ID: 35437825
[TBL] [Abstract][Full Text] [Related]
44. Chemerin and Cancer.
Treeck O; Buechler C; Ortmann O
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370263
[TBL] [Abstract][Full Text] [Related]
45. Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses
Regan-Komito D; Valaris S; Kapellos TS; Recio C; Taylor L; Greaves DR; Iqbal AJ
Front Immunol; 2017; 8():1621. PubMed ID: 29209334
[TBL] [Abstract][Full Text] [Related]
46. Transient expression of recombinant ACKR4 (CCRL1) gene, an atypical chemokine receptor in human embryonic kidney (HEK 293) cells.
Parsi B; Esmaeili A; Hashemi M; Behjati M
Mol Biol Rep; 2016 Jul; 43(7):583-9. PubMed ID: 27168154
[TBL] [Abstract][Full Text] [Related]
47. Atypical chemokine receptor CCRL2 is overexpressed in prostate cancer cells.
Reyes N; Benedetti I; Rebollo J; Correa O; Geliebter J
J Biomed Res; 2017 Nov; 33(1):17-23. PubMed ID: 29497024
[TBL] [Abstract][Full Text] [Related]
48. Regulation of breast cancer metastasis by atypical chemokine receptors.
Cheng X; Hung MC
Clin Cancer Res; 2009 May; 15(9):2951-3. PubMed ID: 19383808
[TBL] [Abstract][Full Text] [Related]
49. Commentary: If you cram you get SAM.
McCarthy PM; Bolling SF
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):578-579. PubMed ID: 32305194
[No Abstract] [Full Text] [Related]
50. RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis.
Ma B; Herzog EL; Moore M; Lee CM; Na SH; Lee CG; Elias JA
Sci Rep; 2016 May; 6():26299. PubMed ID: 27198666
[TBL] [Abstract][Full Text] [Related]
51. High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer.
Wang Z; Ren H; Zhu G; Zhang L; Cao H; Chen B
BMC Cancer; 2023 Oct; 23(1):974. PubMed ID: 37828454
[TBL] [Abstract][Full Text] [Related]
52. CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
Yin W; Li Y; Song Y; Zhang J; Wu C; Chen Y; Miao Y; Lin C; Lin Y; Yan D; Chen J; He R
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846258
[TBL] [Abstract][Full Text] [Related]
53. Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines.
Perego S; Sansoni V; Ziemann E; Lombardi G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670492
[TBL] [Abstract][Full Text] [Related]
54. Molecular Basis for CCRL2 Regulation of Leukocyte Migration.
Schioppa T; Sozio F; Barbazza I; Scutera S; Bosisio D; Sozzani S; Del Prete A
Front Cell Dev Biol; 2020; 8():615031. PubMed ID: 33363177
[TBL] [Abstract][Full Text] [Related]
55. CD66b
Horzum U; Yoyen-Ermis D; Taskiran EZ; Yilmaz KB; Hamaloglu E; Karakoc D; Esendagli G
Cancer Immunol Immunother; 2021 Jan; 70(1):75-87. PubMed ID: 32632664
[TBL] [Abstract][Full Text] [Related]
56. The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.
Groblewska M; Litman-Zawadzka A; Mroczko B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456359
[TBL] [Abstract][Full Text] [Related]
57. More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.
Goralski KB; Jackson AE; McKeown BT; Sinal CJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561459
[TBL] [Abstract][Full Text] [Related]
58. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.
Del Prete A; Sozio F; Schioppa T; Ponzetta A; Vermi W; Calza S; Bugatti M; Salvi V; Bernardini G; Benvenuti F; Vecchi A; Bottazzi B; Mantovani A; Sozzani S
Cancer Immunol Res; 2019 Nov; 7(11):1775-1788. PubMed ID: 31484658
[TBL] [Abstract][Full Text] [Related]
59. Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS.
Yoyen-Ermis D; Tunali G; Tavukcuoglu E; Horzum U; Ozkazanc D; Sutlu T; Buyukasik Y; Esendagli G
Sci Rep; 2019 Aug; 9(1):11697. PubMed ID: 31406210
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
